Skip to content

Drug interactions

Ivacaftor + Zafirlukast

Severity: Minor

Ivacaftor and Zafirlukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivacaftor is a sensitive CYP3A4 substrate, and zafirlukast may modestly increase its exposure. Labeling advises dose reduction only with moderate or strong inhibitors, so this weak interaction is generally manageable.

What this interaction means in plain words

Ivacaftor and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ivacaftor belongs to Miscellaneous; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by zafirlukast reduces ivacaftor clearance.

What to do

No dose reduction is generally required; monitor for ivacaftor adverse effects such as headache, abdominal pain and elevated transaminases.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ivacaftor and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ivacaftor with Zafirlukast?

MediHelp rates the interaction as minor. Ivacaftor and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ivacaftor is a sensitive CYP3A4 substrate, and zafirlukast may modestly increase its exposure. Labeling advises dose reduction only with moderate or strong inhibitors, so this weak interaction is generally manageable.

How serious is the interaction between Ivacaftor and Zafirlukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose reduction is generally required; monitor for ivacaftor adverse effects such as headache, abdominal pain and elevated transaminases.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in